These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6394033)

  • 1. [Semisynthetic human insulin in the treatment of diabetes type I. Preliminary experience].
    Vitacolonna E; Consoli A; Capani F
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1849-52. PubMed ID: 6394033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of human insulin on antibody formation in pregnant diabetics and their newborns.
    Chertow BS; Baranetsky NG; Sivitz WI; Swain PA; Grey J; Charles D
    Obstet Gynecol; 1988 Nov; 72(5):724-8. PubMed ID: 3050653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of type 1 diabetes with semisynthetic human insulin. 1 year's experience].
    Lunetta M; Rapisarda S; Leonardi R; Leotta S; Mughini L
    Minerva Endocrinol; 1984; 9(2):125-35. PubMed ID: 6390126
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Semisynthetic human insulin therapy of type 1 diabetics treated with a microinfusor. Preliminary notes on insulin requirements and antibody titer].
    Capani F; Consoli A; Vitacolonna E; Sensi S
    Minerva Endocrinol; 1984; 9(2):167-71. PubMed ID: 6503905
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin antibodies in the maternal and foetal circulation of pregnant diabetic women treated with human insulin of recombinant DNA origin.
    Leiper JM; Fineberg SE; Lunan CB; MacCuish AC
    Diabetes Res; 1984 Jul; 1(2):75-81. PubMed ID: 6397289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin].
    Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P
    Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124
    [No Abstract]   [Full Text] [Related]  

  • 10. [Breast-feeding in reducing regular insulin requirement in postpartum for insulin dependent diabetes mellitus and gestational diabetes mellitus].
    Yang JQ; Xu YH; Gai MY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Mar; 29(3):135-7, 188. PubMed ID: 8082426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin antibodies in juvenile diabetes mellitus. Correlations to diabetic stability, insulin requirement and duration of insulin treatment.
    Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W
    Horm Metab Res; 1982 May; 14(5):227-32. PubMed ID: 7047344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive insulin therapy in pregnancy: strategies for successful implementation in pregestational diabetes mellitus.
    Bernasko J
    J Matern Fetal Neonatal Med; 2007 Feb; 20(2):125-32. PubMed ID: 17437210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
    Giménez M; Conget I; Nicolau J; Pericot A; Levy I
    Acta Diabetol; 2007 Mar; 44(1):34-7. PubMed ID: 17357884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human insulin.
    Raptis S; Dimitriadis G
    Clin Physiol Biochem; 1985; 3(1):29-42. PubMed ID: 3888492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intensified insulin therapy and insulin micro-pumps during pregnancy].
    Galuppi V
    Minerva Endocrinol; 1994 Jun; 19(2):79-83. PubMed ID: 7968932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anaphylactic reaction to human insulin. Successful desensitization].
    Wintermantel C; Fischer N; Müller PH; Velcovsky HG; Lischka G; Eggstein M
    Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1142-5. PubMed ID: 3292191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
    Catargi B; Breilh D; Roger P; Tabarin A
    Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The place of "monocomponent" insulins in diabetes mellitus therapy].
    Teuscher A
    Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.